EMGALITY 120mg 120mg/ml solution for injection in pre-filled pen ELI LILLY ORIGINAL MEDICINE
Chemical substance: galcanezumab
Active substance
Results for the substance galcanezumab
1 result
About this active substance
Galcanezumab is a monoclonal antibody used for the prevention of episodic and chronic migraine. It works by blocking calcitonin gene-related peptide (CGRP), a substance involved in migraine pain mechanisms.
The medication is administered via subcutaneous injection, usually once a month, as directed by a physician. Galcanezumab has shown efficacy in reducing the frequency and severity of migraine episodes.
Common side effects include injection site reactions, constipation, and fatigue. It is important for patients to be monitored to assess treatment response and potential side effects.
Galcanezumab is a modern and effective option for patients suffering from migraines, helping to improve their quality of life.
The medication is administered via subcutaneous injection, usually once a month, as directed by a physician. Galcanezumab has shown efficacy in reducing the frequency and severity of migraine episodes.
Common side effects include injection site reactions, constipation, and fatigue. It is important for patients to be monitored to assess treatment response and potential side effects.
Galcanezumab is a modern and effective option for patients suffering from migraines, helping to improve their quality of life.